Lin Li, Liu Jianwen, Guo Xiufen, Chen Hang, Huang Yu, Zheng Huiying, Chen Wanhua, Chen Lianglong, Chen Liangwan, Chen Zhaoyang
Department of Cardiology, Heart Center of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. China.
Department of Cardiology, Heart Center of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, Fujian, P.R. China.
Heart Rhythm. 2022 Mar;19(3):389-396. doi: 10.1016/j.hrthm.2021.11.027. Epub 2021 Nov 27.
The risk factors for complete atrioventricular block (CAVB) after device closure of perimembranous ventricular septal defect (pmVSD) remain unclear.
The purpose of this study was to analyze the incidence and risk factors for CAVB after device closure for pmVSD.
We reviewed 1884 patients with pmVSD who had undergone successful device occlusion between June 2005 and January 2020. Permanent CAVB was defined as CAVB requiring implantation of a permanent pacemaker (PPM) or extraction of the occluder.
In total, 14 patients (0.7%) developed permanent CAVB. Of these patients, 10 (0.5%) required PPM implantation. Four permanent CAVB occurred within 7 days after the procedure (acute), 2 between 7 and 30 days (subacute), 3 between 30 days and 1 year (late), and 5 more than 1 year (very late). None of the subacute, late, and very late CAVB recovered normal conduction with medication and eventually required device removal or PPM implantation. Four patients with acute CAVB and 1 with subacute CAVB underwent device removal, and 4 (80%) recovered normal conduction. Multivariate regression revealed that the ratio of device to defect size was the only independent risk factor for permanent CAVB (odds ratio 3.027; 95% confidence interval 1.476-6.209; P = .003).
The incidences of permanent CAVB after occlusion for pmVSD and PPM implantation were 0.7% and 0.5%, respectively. The ratio of device to defect size was the only independent risk factor for permanent CAVB. Device removal is an effective therapeutic modality for recovering normal conduction in acute and subacute CAVB patients.
经导管封堵膜周部室间隔缺损(pmVSD)后发生完全性房室传导阻滞(CAVB)的危险因素尚不清楚。
本研究旨在分析经导管封堵pmVSD后CAVB的发生率及危险因素。
我们回顾了2005年6月至2020年1月期间1884例成功接受封堵器封堵的pmVSD患者。永久性CAVB定义为需要植入永久性起搏器(PPM)或取出封堵器的CAVB。
共有14例患者(0.7%)发生永久性CAVB。其中,10例(0.5%)需要植入PPM。4例永久性CAVB发生在术后7天内(急性),2例发生在7至30天之间(亚急性),3例发生在30天至1年之间(晚期),5例发生在1年以上(极晚期)。亚急性、晚期和极晚期CAVB患者均未通过药物恢复正常传导,最终均需要取出封堵器或植入PPM。4例急性CAVB患者和1例亚急性CAVB患者接受了封堵器取出术,其中4例(80%)恢复了正常传导。多因素回归分析显示,封堵器与缺损大小的比值是永久性CAVB的唯一独立危险因素(比值比3.027;95%置信区间1.476 - 6.209;P = 0.003)。
pmVSD封堵术后永久性CAVB和PPM植入的发生率分别为0.7%和0.5%。封堵器与缺损大小的比值是永久性CAVB的唯一独立危险因素。封堵器取出术是恢复急性和亚急性CAVB患者正常传导的有效治疗方式。